SCHEMBL1491936

SCHEMBL1491936

CC(C)c1cc(-c2ccccc2)cc(C(C)C)c1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
MAOA P21397 1/20 0.41
HSD17B10 Q99714 2/20 0.41
CYP3A4 P08684 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 2/20 0.39
HSP90AA1 P07900 2/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37
KDM4E B2RXH2 1/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30903392 0.98 HSD17B10 (0.44) CA1CA2MAOAHSD17B10CYP3A4
SCHEMBL16203407 0.88 IKBKB (0.42) CA1CA2MAOAHSD17B10ALDH1A1
SCHEMBL461449 0.86 CA1 (0.55) CA1CA2CYP3A4TDP1ALDH1A1
SCHEMBL29926096 0.84 CA1 (0.52) CA1CA2CYP3A4TDP1ALDH1A1
Methane SCHEMBL27861345 0.84 CA1 (0.52) CA1CA2CYP3A4TDP1ALDH1A1
SCHEMBL38652582 0.83 CRHBP (0.43) CA1CA2ALDH1A1HSP90AA1GABRA1
SCHEMBL30791043 0.80 ESR1 (0.46) CA1CA2HSD17B10CYP3A4ALDH1A1
SCHEMBL20681182 0.80 ESR1 (0.46) CA1CA2HSD17B10CYP3A4ALDH1A1
SCHEMBL22431501 0.80 CA1 (0.44) CA1CA2ALDH1A1HSP90AA1GABRA1
SCHEMBL8674451 0.80 CA1 (0.44) CA1CA2ALDH1A1HSP90AA1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117753387-A Covalent organic framework nanocapsule material and emulsion acceleration polymerization method thereof 浙江大学 2024-03-26 CN claimed
CN-113004532-A Metamaterial based on covalent organic framework and application of metamaterial in optical device 浙江大学 2021-06-22 CN claimed
CN-122010847-A Synthesis method of 1- [3, 5-bis (1-methylethyl) [1,1' -biphenyl ] -4-yl ] -2-bromo-1H-benzimidazole 安徽大学 2026-05-12 CN disclosed
US-20260082804-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2026-03-19 US disclosed
US-20260047334-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2026-02-12 US disclosed
US-20260042791-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2026-02-12 US disclosed
US-20250324904-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2025-10-16 US disclosed
US-20250223309-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2025-07-10 US disclosed
EP-4541802-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2025-04-23 EP disclosed
US-12281129-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2025-04-22 US disclosed
CN-119528990-A Organic electroluminescent material and device 环球展览公司 2025-02-28 CN disclosed
US-8586204-B2 Phosphorescent emitters and host materials with improved stability UNIVERSAL DISPLAY CORPORATION (US) 2013-11-19 US disclosed
US-8586204-B2 Phosphorescent emitters and host materials with improved stability UNIVERSAL DISPLAY CORPORATION (US) 2013-11-19 US disclosed
US-20120223634-A1 NOVEL TETRADENTATE PLATINUM COMPLEXES UNIVERSAL DISPLAY CORPORATION (US) 2012-09-06 US disclosed
US-20120223634-A1 NOVEL TETRADENTATE PLATINUM COMPLEXES UNIVERSAL DISPLAY CORPORATION (US) 2012-09-06 US disclosed
US-20120223634-A1 NOVEL TETRADENTATE PLATINUM COMPLEXES UNIVERSAL DISPLAY CORPORATION (US) 2012-09-06 US disclosed
WO-2012116231-A2 NOVEL TETRADENTATE PLATINUM COMPLEXES UNIVERSAL DISPLAY CORPORATION (US) 2012-08-30 WO disclosed
US-20110057559-A1 PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY UNIVERSAL DISPLAY CORPORATION (US) 2011-03-10 US disclosed
US-20110057559-A1 PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY UNIVERSAL DISPLAY CORPORATION (US) 2011-03-10 US disclosed
US-20110057559-A1 PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY UNIVERSAL DISPLAY CORPORATION (US) 2011-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260082804-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LBR, LDLR, LIFR CA1 2693/4885CA2 3217/4885MAOA 1326/4885
US-20260047334-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LBR, LDLR, OXER1 CA1 2980/4885CA2 3201/4885MAOA 1651/4885
US-20110057559-A1 PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY DDT, TPST2, NUDT1 CA1 4592/4885CA2 4497/4885MAOA 1409/4885
US-12281129-B2 Organic electroluminescent materials and devices OCIAD1, OCIAD2, OSBP CA1 4598/4885CA2 4231/4885MAOA 419/4885
US-20250324904-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES MLX, LOXL1, LOXL4 CA1 3354/4885CA2 3569/4885MAOA 300/4885
US-20260042791-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LBR, GLRA1, MSL1 CA1 2979/4885CA2 3497/4885MAOA 2641/4885
US-20120223634-A1 NOVEL TETRADENTATE PLATINUM COMPLEXES PDCD1LG2, TEC, TPR CA1 1636/4885CA2 1359/4885MAOA 3638/4885
US-20250223309-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES MLX, LOXL1, LOXL4 CA1 3354/4885CA2 3569/4885MAOA 300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.